Matches in SemOpenAlex for { <https://semopenalex.org/work/W4298078804> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W4298078804 endingPage "90" @default.
- W4298078804 startingPage "586" @default.
- W4298078804 abstract "Steroids have been beneficial in the treatment of demyelinating diseases with features similar to those of Guillain-Barré syndrome (GBS). However, steroid treatment of GBS has been disappointing; in an earlier trial oral prednisolone was ineffective, although the dose was low and the sample small. We assessed the benefit of a high-dose steroid regimen in a large sample of patients with GBS in a multicentre, randomised, double-blind trial. 242 adult patients were randomised to receive intravenous methylprednisolone (IVMP) 500 mg (124 patients) or a placebo (118) daily for 5 days. Patients were diagnosed by standard clinical criteria and entered the trial within 15 days of onset of neurological symptoms. All patients were too weak to run. Some patients received plasma exchange depending on the practice of their centre. Disability was graded on a scale from 0 (healthy) to 6 (dead) at intervals for 48 weeks. There was no significant difference in any outcome variable between patients treated with IVMP and those given placebo. The most important outcome was the difference between the groups in disability grade 4 weeks after randomisation, which was only a 0.06 grade (95% Cl -0.23 to 0.36) greater improvement in the IVMP than the placebo group. The 39 patients in the IVMP group who required ventilation did so for a median of 18 days, 9 days fewer than the 44 patients who had a placebo and required ventilation (95% Cl -9.6 to 27.6). Median time to walk unaided was 38 days in the IVMP patients and 50 days in the placebo patients (difference 12 days, (95% Cl -21.3 to 45.3). A short course of high-dose IVMP given early in GBS is ineffective." @default.
- W4298078804 created "2022-10-01" @default.
- W4298078804 date "1993-03-06" @default.
- W4298078804 modified "2023-09-29" @default.
- W4298078804 title "Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Guillain-Barré Syndrome Steroid Trial Group." @default.
- W4298078804 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8094828" @default.
- W4298078804 hasPublicationYear "1993" @default.
- W4298078804 type Work @default.
- W4298078804 citedByCount "27" @default.
- W4298078804 countsByYear W42980788042013 @default.
- W4298078804 countsByYear W42980788042015 @default.
- W4298078804 countsByYear W42980788042016 @default.
- W4298078804 countsByYear W42980788042017 @default.
- W4298078804 countsByYear W42980788042019 @default.
- W4298078804 countsByYear W42980788042022 @default.
- W4298078804 countsByYear W42980788042023 @default.
- W4298078804 crossrefType "journal-article" @default.
- W4298078804 hasConcept C141071460 @default.
- W4298078804 hasConcept C142724271 @default.
- W4298078804 hasConcept C168563851 @default.
- W4298078804 hasConcept C187212893 @default.
- W4298078804 hasConcept C204787440 @default.
- W4298078804 hasConcept C27081682 @default.
- W4298078804 hasConcept C2776715498 @default.
- W4298078804 hasConcept C2778691916 @default.
- W4298078804 hasConcept C2780372218 @default.
- W4298078804 hasConcept C2781413609 @default.
- W4298078804 hasConcept C42219234 @default.
- W4298078804 hasConcept C71924100 @default.
- W4298078804 hasConceptScore W4298078804C141071460 @default.
- W4298078804 hasConceptScore W4298078804C142724271 @default.
- W4298078804 hasConceptScore W4298078804C168563851 @default.
- W4298078804 hasConceptScore W4298078804C187212893 @default.
- W4298078804 hasConceptScore W4298078804C204787440 @default.
- W4298078804 hasConceptScore W4298078804C27081682 @default.
- W4298078804 hasConceptScore W4298078804C2776715498 @default.
- W4298078804 hasConceptScore W4298078804C2778691916 @default.
- W4298078804 hasConceptScore W4298078804C2780372218 @default.
- W4298078804 hasConceptScore W4298078804C2781413609 @default.
- W4298078804 hasConceptScore W4298078804C42219234 @default.
- W4298078804 hasConceptScore W4298078804C71924100 @default.
- W4298078804 hasIssue "8845" @default.
- W4298078804 hasLocation W42980788041 @default.
- W4298078804 hasOpenAccess W4298078804 @default.
- W4298078804 hasPrimaryLocation W42980788041 @default.
- W4298078804 hasRelatedWork W2005489834 @default.
- W4298078804 hasRelatedWork W2014854425 @default.
- W4298078804 hasRelatedWork W2119092810 @default.
- W4298078804 hasRelatedWork W2125800402 @default.
- W4298078804 hasRelatedWork W2141301273 @default.
- W4298078804 hasRelatedWork W2210860350 @default.
- W4298078804 hasRelatedWork W2409178060 @default.
- W4298078804 hasRelatedWork W2942456504 @default.
- W4298078804 hasRelatedWork W2952621927 @default.
- W4298078804 hasRelatedWork W4220745402 @default.
- W4298078804 hasVolume "341" @default.
- W4298078804 isParatext "false" @default.
- W4298078804 isRetracted "false" @default.
- W4298078804 workType "article" @default.